Improving Alzheimer’s diagnosis in older adults with multiple chronic conditions
Official title: Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network
Funded at Wake Forest University Health Sciences · NIH-11143134 · Data updated 2026-11-12
This study is looking at how blood tests can help doctors more accurately diagnose Alzheimer’s and related dementias in older adults who have other health issues, making it easier for everyone to get the right care they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | September 15, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,787,678 |
| NIH project number | 5U24AG082930-03 |
| Project ID | NIH-11143134 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults diagnosed with Alzheimer’s disease or related dementias who also have multiple chronic conditions.
✕Less likely to help
Patients without Alzheimer’s disease or related dementias, or those without any chronic conditions, may not benefit from this research.
What this research studies
This research focuses on enhancing the accuracy of Alzheimer’s disease and related dementias (ADRD) diagnosis in older adults who also have multiple chronic conditions. By utilizing blood-based biomarkers, the study aims to provide a more effective and less invasive method for diagnosing ADRD, which could lead to better individualized care pathways. The research will explore how these biomarkers can be integrated into routine clinical practice, particularly for diverse populations and those with limited life expectancy. It seeks to understand the relationship between chronic conditions and biomarker levels to improve diagnostic and prognostic capabilities.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of Alzheimer’s disease, allowing for better treatment options and care strategies for patients.
How similar studies have gone: While the use of blood-based biomarkers for diagnosing ADRD is a relatively novel approach, similar studies have shown promise in improving diagnostic accuracy in other contexts.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Mielke, Michelle M — Wake Forest University Health Sciences
- Study coordinator: Mielke, Michelle M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.